- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01158066
Association Between Non-alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Calcification
April 5, 2011 updated by: Ziv Hospital
Association Between NAFLD and Coronary Artery Calcification
Coronary artery disease are 8 times more prevalent in patients with NAFLD then the general population and are being considered the most common cause of death.
Cardiac CT is a reliable non invasive method in demonstrating Coronary Plaques.
However the association between coronary artery calcium score (CAC) and NAFLD remains controversial
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Coronary artery disease are 8 times more prevalent in patients with NAFLD that the general population and are being considered the most common cause of death.
Cardiac CT is a reliable non invasive method in demonstrating Coronary Plaques.
However the association between coronary artery calcium score (CAC) and NAFLD remains controversial.
AIM: the aim is to evaluate the association between CAC score ( CT) and NAFLD (CT). the working hypothesis is that Beside the traditional risk factors including age, diabetes, NAFLD is also associated with moderate to high risk of CAD.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Safed, Israel, Israel, 13100
- Ziv medical center liver unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who will undergo cardiac CT for patients with low to intermediate risk for CAD
Exclusion Criteria:
- Patients with PCI or CABG will be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: CT cardiac
the patient will undergo cardiac CT
|
the patient will undergo cardiac CT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total calcium score measurement
Time Frame: 1 month
|
total calcium score will be measured
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Anticipated)
January 1, 2012
Study Completion (Anticipated)
March 1, 2012
Study Registration Dates
First Submitted
July 4, 2010
First Submitted That Met QC Criteria
July 7, 2010
First Posted (Estimate)
July 8, 2010
Study Record Updates
Last Update Posted (Estimate)
April 6, 2011
Last Update Submitted That Met QC Criteria
April 5, 2011
Last Verified
June 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NAFLD and CAC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Calcification
-
Centre Hospitalier Régional d'OrléansNot yet recruitingCoronary Artery Disease | Coronary Artery Calcification
-
Shanghai MicroPort Rhythm MedTech Co., Ltd.RecruitingCoronary Artery CalcificationChina
-
Chinese PLA General HospitalCompleted
-
Chinese PLA General HospitalUnknown
-
First Affiliated Hospital of Chongqing Medical...UnknownCoronary Artery CalcificationChina
-
Stanford UniversityRecruitingCoronary Artery CalcificationUnited States
-
University of Rome Tor VergataRecruitingCoronary Artery CalcificationItaly
-
National Heart Centre SingaporeBoston Scientific CorporationRecruitingCoronary Artery CalcificationSingapore, Japan
-
University Hospital OstravaRecruitingCoronary Artery CalcificationCzechia
-
VeraLight, Inc.New Mexico Heart Institute, PACompletedDiabetes | Coronary Artery CalcificationUnited States
Clinical Trials on CT Cardiac
-
Assiut UniversityNot yet recruitingCardiac Congenital Defects
-
Das Radiologische ZentrumHeidelberg UniversityRecruiting
-
Piedmont HealthcareCompletedCoronary Artery DiseaseUnited States
-
Hospital of South West JutlandUniversity of Southern Denmark; The Danish Diabetes Academy supported by the... and other collaboratorsUnknownDiabetes | Atherosclerosis | PlaqueDenmark
-
Odense University HospitalUnknownCoronary ArteriosclerosisDenmark
-
Guy's and St Thomas' NHS Foundation TrustUnknownCoronary Artery Disease | Chest Pain | Acute Coronary Syndrome | Ischemic Heart DiseaseUnited Kingdom
-
Medical University of ViennaUniversity College, LondonUnknown
-
NHS Greater Glasgow and ClydeTerminatedCardiovascular Diseases | Chronic Kidney Diseases | Cardiomyopathies | Cardiac DiseaseUnited Kingdom
-
Carmel Medical CenterArineta Ltd.Unknown